Tinea Versicolor Treatment Market Projected to Grow Radiantly By 2023 | Industry Growth Influencer - Astellas Pharma , Inc. , Bayer AG , Enzon Pharmaceuticals, Inc. , Galderma S.A., Gilead, Novartis AG , Pfizer Inc.

A Broad Analysis of the "Worldwide Salivary gland infection market “methodology of the leading organizations in the exactness of import/export utilization, market activity figures, cost, value, revenue and gross edges.

Tinea Versicolor Treatment Market -Overview

Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk.

Increasing prevalence of tinea versicolor, increasing awareness of the disease, rising healthcare expenditure, advanced diagnosis and treatment options, and approval of new antifungal medicines are leading the growth of global tinea versicolor treatment market.

Global tinea versicolor treatment market is expected to grow at the CAGR of ~7.1% during the forecast period and is estimated to reach USD 197.9 million by 2023.

Tinea Versicolor Treatment Market -Market Segments

Global tinea versicolor treatment market has been segmented on the basis of diagnosis which comprise physical exam, imaging tests, and others. Imaging test is sub-segmented into wood lamp (black light) examination, microscopy using potassium hydroxide (KOH), fungal culture, skin biopsy, and others. Skin biopsy is sub-segmented into shave biopsy, punch biopsy, excisional biopsy, and others.

On the basis of treatments, the market has been segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are sub-segmented into selenium sulfide (selsun) 2.5 percent shampoo, ciclopirox (loprox, penlac) shampoo, ketoconazole (ketoconazole, nizoral, others) shampoo, and others. Antifungal creams are sub-segmented into Selenium sulfide (Selsun) 2.5 percent lotion, Ciclopirox (Loprox, Penlac) cream or gel, Ketoconazole (Ketoconazole, Nizoral, others) cream or gel, and others. Drugs are further sub-segmented into fluconazole (diflucan) tablets or oral solution, and others.

Get PDF with Technological Advancement @ https://www.marketresearchfuture.com/sample_request/3878

Tinea Versicolor Treatment Market -Key developments

Major players in the market are engaged in the development of new products to capture the market globally. Thus, key market players are investing more in research and development activity, in order to lead the global market. In this regards, market players undertake various strategic approaches.

In March 2016, Novartis cancer drug gets FDA's principal 'biosimilar' affirmation. Federal regulators have permitted the first “biosimilar” drug to be sold in the U.S. under a program intended to branch a new market of lower-cost substitutes to some of the most expensive treatments in healthcare.

In May 2016, Novartis studies new sales model for tentative cancer therapy. Novartis strategies to use a medical device-like sales model to market its CAR T-cell technology if the new cancer treatment receives FDA approval.

Tinea Versicolor Treatment Market -Regional Analysis

Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly include North America and South America. Due to large amount of money invested in research, clinical trials, and new product development, US is the dominating country in this region.

Europe is the second largest market for tinea versicolor treatment. Germany is dominating this market while UK is the fastest growing tinea versicolor treatment market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly improving healthcare facilities, increasing awareness of disease, and rising healthcare expenditure. Middle East & Africa is expected to have limited growth.

Obtain Report Details with Technological Advancement @ https://www.marketresearchfuture.com/reports/tinea-versicolor-treatment-market-3878

Tinea Versicolor Treatment Market -Key Players

Astellas Pharma US, Inc. (Japan)
Bayer AG (German)
Enzon Pharmaceuticals, Inc. (US)
Galderma S.A. (Switzerland)
Gilead (US)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Taro Pharmaceutical Industries Ltd. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Valeant (Canada)

Major Points form TOC for Tinea Versicolor Treatment Market Research Report – Forecast to 2023

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Tinea Versicolor Treatment Market, By Type

Chapter 7. Global Tinea Versicolor Treatment Market, By Treatment

Chapter 8 Global Tinea Versicolor Treatment Market, By End User

Chapter 9. Global Tinea Versicolor Treatment Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion

Chapter 13. Appendix

Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/3878

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.